Skip to content

September 17, 2026

Rakesh Jhunjhunwala

Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Articles
Portfolios
- Rakesh Jhunjhunwala Latest Portfolio
- Dolly Khanna Latest Portfolio, Holdings, Wiki, News | December 2023
Top Stock Picks 2026 | Live Portfolio Tracker

Light/Dark Button

Search for:

Home
DOWNLOADS

DOWNLOADS

Subscribe to Telegram Channel

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address

Join 609 other subscribers

Recent Comments

KOTHARI SL on List of 50 High Dividend Yield Stocks as of 2nd September 2026 by SBI Securities
GOKULNATH SADHWANI on BEML has evolved from a conventional mining and rail equipment manufacturer into an indigenous mobility and defence platform. Target price is ₹2765 (36% upside): ICICI Direct
RAVI VADHGELA Vadhgela ravi on Ashish Kacholia’s Winning Bet on Indo SMC: Stock Soars 201% Since IPO as Strong Earnings and Order Wins Fuel Growth
R K Duvedi on List of 50 High Dividend Yield Stocks as of 2nd September 2026 by SBI Securities
sudhakar ramdas sonawane on List of 50 High Dividend Yield Stocks as of 2nd September 2026 by SBI Securities

Search for:

Recent Posts

Pondy Oxide is moving beyond recycling to unlock higher growth. Buy for target price of ₹625 (35% upside): ICICI Direct
Nephrocare Health Services is a large scale dialysis player with global aspirations. Target price is ₹900 (18% upside): ICICI Direct
NAM India has a multi-year investment opportunity from Japan. Buy for target price of ₹1395 (18% upside): BOB Caps
Raymond Realty is a premium focused play in MMR. Buy for target price of ₹700 (23% upside): ICICI Direct
LGEIL is well-positioned for structural growth and margin recovery. Buy for target price is ₹1965: Axis Securities

You may have missed

Pondy Oxide share price target

investments

Pondy Oxide is moving beyond recycling to unlock higher growth. Buy for target price of ₹625 (35% upside): ICICI Direct

September 16, 2026 0

nephrocare health services share price target

investments

Nephrocare Health Services is a large scale dialysis player with global aspirations. Target price is ₹900 (18% upside): ICICI Direct

September 15, 2026 0

nam india share price target

investments

NAM India has a multi-year investment opportunity from Japan. Buy for target price of ₹1395 (18% upside): BOB Caps

September 14, 2026 0

Raymond Realty share price target

investments

Raymond Realty is a premium focused play in MMR. Buy for target price of ₹700 (23% upside): ICICI Direct

September 13, 2026 0

lgeil share price target

investments

LGEIL is well-positioned for structural growth and margin recovery. Buy for target price is ₹1965: Axis Securities

September 12, 2026 0

Kirloskar Oil Engines share price target

investments

Kirloskar Oil Engines is entering a new phase of structural growth. Buy for target price of ₹2850 (28% upside): ICICI Direct

September 11, 2026 0

Copyright © All rights reserved. | ChromeNews by AF themes.